• Profile
Close

Fibrinolysis vs primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock

ESC Heart Failure Mar 23, 2021

Vallabhajosyula S, Verghese D, Bell MR, et al. - Researchers utilized the National (Nationwide) Inpatient Sample from 2009 to 2017 in this large national observational study to compare outcomes among adult (> 18 years) ST‐segment elevation myocardial infarction cardiogenic shock (STEMI‐CS) admissions receiving initial fibrinolysis vs primary percutaneous coronary intervention (PPCI). Higher rates of haemorrhagic complications were reported in the fibrinolysis group. Comparable rates of acute organ failure, hospital length of stay, rates of palliative care referrals, do‐not‐resuscitate status use, and lesser hospitalization expenditures were found in the fibrinolysis group. In the contemporary era, in‐hospital mortality associated with the use of initial fibrinolysis was comparable to that noted in patients who received PPCI in STEMI‐CS.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay